Growth Metrics

Merck (MRK) Retained Earnings (2016 - 2025)

Merck (MRK) has disclosed Retained Earnings for 17 consecutive years, with -$4.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 106.8% to -$4.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.3 billion, a 106.8% decrease, with the full-year FY2025 number at -$4.3 billion, down 106.8% from a year prior.
  • Retained Earnings was -$4.3 billion for Q4 2025 at Merck, down from $72.2 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $72.2 billion in Q3 2025 to a low of -$4.9 billion in Q1 2023.
  • A 5-year average of $37.4 billion and a median of $55.2 billion in 2022 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: crashed 109.35% in 2021, then soared 1479.11% in 2022.
  • Merck's Retained Earnings stood at -$4.4 billion in 2021, then skyrocketed by 1479.11% to $61.1 billion in 2022, then dropped by 11.76% to $53.9 billion in 2023, then grew by 17.02% to $63.1 billion in 2024, then plummeted by 106.8% to -$4.3 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Retained Earnings are -$4.3 billion (Q4 2025), $72.2 billion (Q3 2025), and $68.5 billion (Q2 2025).